Gamco Investors INC. ET AL acquired a new stake in shares of Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 44,760 shares of the medical equipment provider’s stock, valued at approximately $192,000.

Several other institutional investors have also added to or reduced their stakes in CVRS. Cambridge Investment Research Advisors Inc. bought a new position in shares of Corindus Vascular Robotics in the third quarter worth about $39,000. Steward Partners Investment Advisory LLC raised its stake in Corindus Vascular Robotics by 36.4% during the 2nd quarter. Steward Partners Investment Advisory LLC now owns 15,000 shares of the medical equipment provider’s stock valued at $44,000 after purchasing an additional 4,000 shares during the period. Tealwood Asset Management Inc. raised its stake in Corindus Vascular Robotics by 50.0% during the 2nd quarter. Tealwood Asset Management Inc. now owns 15,000 shares of the medical equipment provider’s stock valued at $45,000 after purchasing an additional 5,000 shares during the period. D. E. Shaw & Co. Inc. bought a new stake in Corindus Vascular Robotics during the 2nd quarter valued at approximately $58,000. Finally, Cubist Systematic Strategies LLC bought a new stake in Corindus Vascular Robotics during the 2nd quarter valued at approximately $97,000.

Several analysts recently issued reports on CVRS shares. Cowen downgraded Corindus Vascular Robotics from an “outperform” rating to a “market perform” rating and lifted their target price for the company from $4.00 to $4.28 in a research note on Thursday, August 8th. Zacks Investment Research downgraded Corindus Vascular Robotics from a “hold” rating to a “sell” rating in a research note on Tuesday, August 13th.

CVRS remained flat at $$4.27 on Wednesday. Corindus Vascular Robotics Inc has a 52 week low of $0.78 and a 52 week high of $4.40.

Corindus Vascular Robotics Profile

Corindus Vascular Robotics, Inc designs, manufactures, and sells robotic-assisted systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for coronary and peripheral interventional procedures.

Read More: What are the reasons investors use put options?

Institutional Ownership by Quarter for Corindus Vascular Robotics (NYSEAMERICAN:CVRS)

Receive News & Ratings for Corindus Vascular Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corindus Vascular Robotics and related companies with MarketBeat.com's FREE daily email newsletter.